These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Hot off the breath: A big step forward for idiopathic pulmonary fibrosis. Ryerson CJ; Collard HR Thorax; 2014 Sep; 69(9):791-2. PubMed ID: 24996636 [No Abstract] [Full Text] [Related]
3. Forced vital capacity in idiopathic pulmonary fibrosis--FDA review of pirfenidone and nintedanib. Karimi-Shah BA; Chowdhury BA N Engl J Med; 2015 Mar; 372(13):1189-91. PubMed ID: 25806913 [No Abstract] [Full Text] [Related]
4. Novel treatments for idiopathic pulmonary fibrosis. Spagnolo P Am J Med; 2015 May; 128(5):447-9. PubMed ID: 25613299 [No Abstract] [Full Text] [Related]
5. Clinical trial research in focus: why do so many clinical trials fail in IPF? Spagnolo P; Maher TM Lancet Respir Med; 2017 May; 5(5):372-374. PubMed ID: 28412184 [No Abstract] [Full Text] [Related]
6. Update in diffuse parenchymal lung disease, 2013. Rosas IO; Kaminski N Am J Respir Crit Care Med; 2015 Feb; 191(3):270-4. PubMed ID: 25635490 [TBL] [Abstract][Full Text] [Related]
7. New guideline on treatment of idiopathic pulmonary fibrosis. Spagnolo P; Bonella F; Maher TM Lancet Respir Med; 2015 Sep; 3(9):e31-e32. PubMed ID: 26380887 [No Abstract] [Full Text] [Related]
8. Nintedanib and pirfenidone. New antifibrotic treatments indicated for idiopathic pulmonary fibrosis offer hopes and raises questions. Raghu G; Selman M Am J Respir Crit Care Med; 2015 Feb; 191(3):252-4. PubMed ID: 25635489 [No Abstract] [Full Text] [Related]
9. Therapeutic advances in idiopathic pulmonary fibrosis. George G; Vaid U; Summer R Clin Pharmacol Ther; 2016 Jan; 99(1):30-2. PubMed ID: 26502087 [No Abstract] [Full Text] [Related]
10. Two therapies now available for idiopathic pulmonary fibrosis. Morrow T Manag Care; 2014 Dec; 23(12):47-8. PubMed ID: 25939185 [No Abstract] [Full Text] [Related]
11. Regulatory watch: Surprise setback for lung fibrosis drug highlights trial challenges. Nat Rev Drug Discov; 2010 Jul; 9(7):506. PubMed ID: 20592735 [No Abstract] [Full Text] [Related]
12. Recommendations for perioperative management of new pharmacological antifibrotic therapy in idiopathic pulmonary fibrosis. González Larrocha O; Romero Rojano P; Ortega Mera U; Arízaga Maguregui A Rev Esp Anestesiol Reanim (Engl Ed); 2018 Mar; 65(3):178-179. PubMed ID: 29183632 [No Abstract] [Full Text] [Related]
18. Update in Interstitial Lung Disease 2014. Belloli EA; Martinez FJ; Flaherty KR Am J Respir Crit Care Med; 2015 Sep; 192(5):538-43. PubMed ID: 26561676 [No Abstract] [Full Text] [Related]
19. The questionable efficacy of pirfenidone in IPF. Mathai SC; Polito AJ Am J Respir Crit Care Med; 2005 Nov; 172(9):1228. PubMed ID: 16249323 [No Abstract] [Full Text] [Related]
20. Idiopathic pulmonary fibrosis: the turning point is now! Funke M; Geiser T Swiss Med Wkly; 2015; 145():w14139. PubMed ID: 26024356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]